Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Great Start GeneticsDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of PolyphotonixCancer medical diagnosis improvements in England: an interview with Lucy Elliss-BrookesThese awards are a part of a Department-wide work to handle HAIs. Funded tasks will contribute to applying the strategies outlined in the HHS Actions Intend to Prevent Healthcare-Associated Infections.These are not usually regarded in the evaluation and treatment of young patients,’ said Dr. Talarico. ‘Increasing life expectancy has led to a rise in the U.S. Elderly population, making it even more critical that elderly cancer sufferers have better access to clinical cancer remedies and trials,’ Dr. Talarico added. ‘With the development of brand-new, selective, and better tolerated remedies, improved access ought to be possible.’.. ARTs safe without program lab tests, Lancet study finds A Lancet study published online Tuesday validates the security of administering first-line antiretroviral therapy to individuals with HIV without routine toxicity and efficacy tests, ‘[b]ut tests of immune-system function might still be a good idea to monitor the progression of the disease and guide the second year of treatment,’ HealthDay/U.S.